Medtronic, Inc Patent Portfolio Statistics

Medtronic, Inc.

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Medtronic, Inc. look like?

Assignee Art Units
Total Applications: 8,048 2,205,352
Granted Patents: 5,786 1,292,663
Grant Index 80.89% 72.38%
Abandoned/Rejected Applications: 1,367 (19.11%) 493,234 (27.62%)
In-Process Applications: 854 419,455
Average Grant Time: 3.73 Years 2.74 Years
Average Office Actions: 2.28 1.62

Which Technology Area Medtronic, Inc. is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
3762 Refrigeration, Vaporization, Ventilation, and Combustion 1,474
3766 Medical Instruments, Diagnostic Equipment, and Treatment Devices 1,301
3792 Medical Instruments, Diagnostic Equipment, and Treatment Devices 824
Opap Parked GAU 338
3763 Refrigeration, Vaporization, Ventilation, and Combustion 284

How many patents are Medtronic, Inc. filing every year?

Year Total Applications Predicted
2022 0* 489
2021 235* 437
2020 355 490
2019 252 252
2018 260
2017 261
2016 233
2015 265
2014 286
2013 266

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Medtronic, Inc. in USPTO?

Publication number: US20220176128A1
Application number: 17/552,866

This disclosure relates to methods, devices, and systems for delivering and adjusting stimulation therapy. In one example, a method comprising delivering, by a stimulation electrode, electrical stimulation as a candidate therapy to a patient according to a set of candidate therapy parameters, the stimulation electrode located in proximity to the dorsal column of a patient; sensing, by a sensing electrode, an electrically evoked compound action potential (eECAP) signal in response to the delivery of the electrical stimulation; and classifying, by a processor, the sensed eECAP signal generated in response to the application of the candidate therapy relative to an eECAP baseline is disclosed.

Publication date: 2022-06-09
Applicant: Medtronic, Inc.
Inventors: Denison J Timothy

Publication number: US20220105348A1
Application number: 17/552,813

Devices, systems, and methods may manage therapy delivery to a patient based on one or more physiological markers. In some examples, a method includes detecting a physiological marker that occurs prior in time to a dysfunctional phase of a physiological cycle, wherein a dysfunctional state of the physiological cycle occurs during the dysfunctional phase without treatment, responsive to detecting the physiological marker, initiating a first phase of the physiological cycle having a duration of time. The method may also include, responsive to the first phase elapsing, controlling a therapy delivery module to deliver neurostimulation therapy during a second phase that begins prior to the dysfunctional phase, wherein the neurostimulation therapy is configured to treat the dysfunctional state.

Publication date: 2022-04-07
Applicant: Medtronic, Inc.
Inventors: Lance Zirpel

Publication number: US20220143400A1
Application number: 17/549,863

A shield located within an implantable medical lead may be terminated in various ways at a metal connector. The shield may be terminated by various joints including butt, scarf, lap, or other joints between insulation layers surrounding the lead and an insulation extension. The shield may terminate with a physical and electrical connection to a single metal connector. The shield may terminate with a physical and electrical connection by passing between an overlapping pair of inner and outer metal connectors. The metal connectors may include features such as teeth or threads that penetrate the insulation layers of the lead. The shield may terminate with a physical and electrical connection by exiting a jacket of a lead adjacent to a metal connector and lapping onto the metal connector.

Publication date: 2022-05-12
Applicant: Medtronic, Inc.
Inventors: Bruce Mehdizadeh R

How are Medtronic, Inc.’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/552,866 Dorsal Spinal Column Characterization With Evoked Potentials OPAP Central, Docket
17/552,813 Managing Therapy Delivery Based On Physiological Markers Docketed New Case – Ready for Examination OPAP Central, Docket
17/549,863 Termination Of A Shield Within An Implantable Medical Lead Docketed New Case – Ready for Examination OPAP Central, Docket
17/550,336 Methods And Devices That Utilize Hardware To Move Blocks Of Operating Parameter Data From Memory To A Register Set Docketed New Case – Ready for Examination OPAP Central, Docket
17/548,201 Compact Implantable Medical Device And Delivery Device Docketed New Case – Ready for Examination OPAP Central, Docket